Citius Oncology (CTOR) vs OnKure Therapeutics (OKUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
OnKure Therapeutics (OKUR) has outperformed Citius Oncology (CTOR) over the past year, losing 21.4% versus a loss of 54.7%. OnKure Therapeutics is the larger company by market cap ($95.2 million vs $90.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | OKUR |
|---|---|---|
| Share price | $0.851 | $2.35 |
| Market cap | $90.00M | $95.17M |
| 1-day change | +0.12% | -4.47% |
| YTD return | -14.90% | -18.97% |
| 1-year return | -54.73% | -21.40% |
| 5-year return | — | -96.35% |
| EPS (TTM) | $-0.48 | $-3.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $5.38 |
| 52-week low | $0.491 | $2.23 |
| Distance from 52-week high | -62.18% | -56.32% |
| Average volume | 98.81K | 210.66K |
| Shares outstanding | 105.76M | 40.50M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OKUR has outperformed CTOR by 33.3 percentage points over the past year.
CTOR vs OKUR FAQ
Which is bigger, Citius Oncology or OnKure Therapeutics?
OnKure Therapeutics (OKUR) is larger, with a market capitalization of $95.17M compared with $90.00M for Citius Oncology (CTOR).
Which stock has performed better over the past year, CTOR or OKUR?
OKUR returned -21.40% over the past 12 months, compared with -54.73% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and OnKure Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.